Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Spetzler

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Cancer Medicine|July 10, 2020
Population bias in somatic measurement of microsatellite instability statusMichelle Saul, Kelsey Poorman, Hongseok Tae, et al.
JAMA Oncology|June 26, 2025
A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid TumorsDave Bryant, Rebecca Feldman, Farah Abdulla, et al.
Oncotarget|March 1, 2018
Ependymomas overexpress chemoresistance and DNA repair-related proteinsSherise D Ferguson, Shouhao Zhou, Joanne Xiu, et al.
Neuro-Oncology Advances|May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapyPatricia Pittman, Chen Sun, Timothy Samec, et al.
Breast Cancer Research : BCR|August 12, 2025
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysisGeorge W Jr Sledge, Joanne Xiu, Jeffrey Peter Solzak, et al.
Oncotarget|March 5, 2016
Impact of molecular profiling on overall survival of patients with advanced ovarian cancerThomas J Herzog, David Spetzler, Nick Xiao, et al.
Gynecologic Oncology|May 9, 2025
Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumorsElizabeth Evans, Jhalak Dholakia, Jim Abraham, et al.
Medical Oncology (Northwood, London, England)|June 8, 2023
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic targetSourat Darabi, Joanne Xiu, Timothy Samec, et al.
Neuro-Oncology Advances|November 18, 2024
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomasSonikpreet Aulakh, Joanne Xiu, Andrew Hinton, et al.
NPJ Precision Oncology|July 31, 2025
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approachEghbal Amidi, Mohammadreza Ramzanpour, Ming Chen, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cancer Medicine|July 10, 2020
Population bias in somatic measurement of microsatellite instability statusMichelle Saul, Kelsey Poorman, Hongseok Tae, et al.
JAMA Oncology|June 26, 2025
A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid TumorsDave Bryant, Rebecca Feldman, Farah Abdulla, et al.
Oncotarget|March 1, 2018
Ependymomas overexpress chemoresistance and DNA repair-related proteinsSherise D Ferguson, Shouhao Zhou, Joanne Xiu, et al.
Neuro-Oncology Advances|May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapyPatricia Pittman, Chen Sun, Timothy Samec, et al.
Breast Cancer Research : BCR|August 12, 2025
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysisGeorge W Jr Sledge, Joanne Xiu, Jeffrey Peter Solzak, et al.
Oncotarget|March 5, 2016
Impact of molecular profiling on overall survival of patients with advanced ovarian cancerThomas J Herzog, David Spetzler, Nick Xiao, et al.
Gynecologic Oncology|May 9, 2025
Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumorsElizabeth Evans, Jhalak Dholakia, Jim Abraham, et al.
Medical Oncology (Northwood, London, England)|June 8, 2023
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic targetSourat Darabi, Joanne Xiu, Timothy Samec, et al.
Neuro-Oncology Advances|November 18, 2024
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomasSonikpreet Aulakh, Joanne Xiu, Andrew Hinton, et al.
NPJ Precision Oncology|July 31, 2025
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approachEghbal Amidi, Mohammadreza Ramzanpour, Ming Chen, et al.
Pageof 9